Immediate Impact

3 from Science/Nature 89 standout
Sub-graph 1 of 20

Citing Papers

Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer
2023 Standout
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
2021 Standout
2 intermediate papers

Works of M. Rinaldini being referenced

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
2006
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
2000
and 1 more

Author Peers

Author Last Decade Papers Cites
M. Rinaldini 403 399 129 498 9 658
A. Fini 330 350 98 447 9 579
Joern Hilfrich 458 405 117 489 11 722
G. Gademann 437 392 127 515 12 723
NR Williams 427 335 145 432 10 746
D F Hayes 451 322 152 226 11 743
Jan Michel 321 276 238 375 6 636
William N. Harwin 475 385 255 526 21 837
Patricia Farmer 374 268 99 393 10 729
Jožica Červek 364 267 201 344 18 694
T Tjabbes 280 285 141 403 12 602

All Works

Loading papers...

Rankless by CCL
2026